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Purpose: To identify the genetic locus and mutation responsible for autosomal dominant cone dystrophy (adCOD) in a
large Chinese family and to describe the phenotypes of the patients.
Methods: Genomic DNA and clinical data were collected from the family. Genome-wide linkage analysis was performed
to map the disease locus, and Sanger dideoxy sequencing was used to detect the mutation in a candidate gene.
Results: Initially, genome-wide linkage analysis mapped the disease to 17p13.1 between D17S831 and D17S799, with a
maximum lod score of 2.71 for D17S938 and D17S1852 at theta=0. Sequence analysis of the guanylate cyclase 2D gene
(GUCY2D) in the linkage interval detected a recurrent heterozygous mutation, c.2513G>A (p.Arg838His). This mutation
was present in all eight patients with adCOD, but neither in any of the six unaffected family members nor in 192 control
chromosomes.
Conclusions: adCOD in this family is caused by a recurrent mutation in GUCY2D. adCOD can be detected in the first
few years after birth in the family by fundus observation and electroretinogram recordings.
Cone dystrophy (COD) is a retinal disease characterized
by the dysfunction or degeneration of cone photoreceptors
that are responsible for central and color vision. COD can be
classified into two major types: stationary and progressive.
Progressive  COD  might  be  difficult  to  differentiate  from
cone-rod  dystrophy  (CORD),  since  some  degree  of  rod
dysfunction develops in the advanced stage of COD [1,2]. It
is  suggested  that  COD  represents  retinal  diseases  with
predominant cone dysfunction with late onset and mild rod
involvement, while CORD indicates retinal degeneration with
early onset cone dysfunction followed shortly thereafter by
significant rod dystrophy [1]. Patients with progressive COD
may complain of photophobia, decreased visual acuity, and
color vision defects. Fundus changes may be nearly normal or
subtle  in  the  early  stage.  In  the  advanced  stage,  macular
degeneration can be observed under an ophthalmoscope.
COD  can  be  inherited  as  an  autosomal  dominant
(adCOD) [3], autosomal recessive (arCOD) [4], or X-linked
trait (xlCOD) [5], although it occurs sporadically in most
cases. At least five loci have been designed for COD, namely
COD1 (OMIM 304020) [5,6], COD2 (OMIM 300085) [7],
COD3 (OMIM 602093) [3], COD4 (OMIM 613093) [4], and
COD5 (OMIM 303700) [8]. Mutations in several genes have
been  identified  to  be  responsible  for  COD,  including
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guanylate cyclase activator 1A (GUCA1A) [3], alpha-prime
cone  cGMP-specific  phosphodiesterase  subunit  (PDE6C)
[4], retinitis pigmentosa GTPase regulator (RPGR) [6], red
and green visual pigment genes (OPN1LW and OPN1MW)
[8], and guanylate cyclase 2D (GUCY2D) [9,10]. However,
no mutation in GUCY2D has been reported in Chinese patients
with COD or CORD.
In the present study, progressive COD was found in a
three-generation  Chinese  family  with  eight  affected
individuals. A genome-wide linkage study mapped the COD
locus to 17p13.1. Sequencing the candidate gene in the linkage
interval  identified  a  recurrent  c.2513G>A  (p.Arg838His)
mutation in GUCY2D (OMIM 600179).
METHODS
Family with cone dystrophy: adCOD was identified in a three-
generation  family  living  in  a  small  town  in  Guandong
province, China. Eight patients and six unaffected individuals
in  the  family  participated  in  this  study.  Written  informed
consent was obtained from the participating individuals or
their  guardians  before  the  collection  of  clinical  data  and
genomic samples. This study was approved by the Internal
Review Board of the Zhongshan Ophthalmic Center, Sun Yat-
sen University, Guangzhou, China and followed the tenets of
the  Declaration  of  Helsinki  and  the  Guidance  of  Sample
Collection  of  Human  Genetic  Diseases  (863-Plan)  of  the
Ministry  of  Public  Health  of  China.  Genomic  DNA  was
prepared from venous leukocytes.
Genotyping and linkage analysis: Genotyping for 14 family
members  was  performed  using  5′-fluorescently  labeled
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3271Figure 1. Pedigree, genotyping haplotypes on 17p13.1, and GUCY2D mutation. Pedigree and haplotypes are shown at the top. Filled squares
(male) or circles (female) represent individuals affected with cone dystrophy. Bars filled with black indicate a disease-associated allele. The
sequence chromatograph of GUCY2D is shown at bottom, in which the double peaks (arrow indicated) demonstrated the heterozygous recurrent
mutation in GUCY2D.
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3273microsatellite markers, as previous described [11]. Briefly, a
genome-wide scan was performed using panels 1 to 27 of the
ABI  PRISM  linkage  Mapping  Set  Version  2  (Applied
Biosystems, Foster City, CA). PCR was conducted at 94 °C
for 8 min, followed by 10 cycles of amplification at 94 °C 15
s, 55 °C 15 s, and 72 °C 30 s; then 20 cycles at 89 °C 15 s,
55 °C 15 s, 72 °C 30 s; and finally at 72 °C for 10 min. After
mixing  with  GENESCANTM  400HD  [ROXTM]  standard
(Applied  Biosystems)  and  deionized  formamide,  the
amplicons  were  denatured  at  95  °C  for  5  min  and  then
immediately placed on ice for 5 min. The amplicons were
separated  on  an  ABI  3100  Genetic  Analyzer  (Applied
Biosystems). Genotyping data were analyzed using the Gene
Mapper version 3.5 software package (Applied Biosystems).
Two-point  linkage  analysis  was  performed  by  using  the
MLINK program of the FASTLINK implementation of the
LINKAGE program package [12,13]. COD in the family was
analyzed as an autosomal dominant trait with full penetrance
and  with  a  disease-gene  allele  frequency  of  0.0001.
Haplotypes were generated using the Cyrillic 2.1 program
(Cyrillic  Software,  Wallingford,  UK)  and  confirmed  by
inspection.
Mutation  identification  in  GUCY2D:  PCR  was  used  to
amplify  the  genomic  fragments  of  GUCY2D.  Primers
employed to amplify the 19 coding exons and their adjacent
intronic region of GUCY2D were the same as those previously
reported [14]. PCR amplifications were performed in 20 µl
reactions containing 80 ng genomic DNA. Touchdown PCR
amplification consisted of a denaturizing step at 95 °C for 5
min, followed by 35 cycles of amplification (at 95 °C for 30
s; at 64–57 °C for 30 s, starting from 64 °C and decreasing by
0.5 °C with every cycle for 14 cycles until remaining at 57 °C
for 21 cycles; and at 72 °C for 40 s) and a final extension at
72 °C for 10 min. The nucleotide sequences of the amplicons
Figure 2. Fundus photos of three patients and a normal control. II:2 and II:7 demonstrated the typical macular atrophy observed in the six
adult patients. III:1 at two and half years old showed mild granular retinal pigment epithelial changes, with the tiny yellowish-white deposits
in the macula observed in the two youngest patients. Temporal pallor of the optic disc was observed in patients II:2, II:7, and III:1. Mild artery
attenuation was noticed in II:2 and II:7. Ctr: fundus photo of a normal control.
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3274were  determined  with  the  ABI  BigDye  Terminator  cycle
sequencing kit v3.1 (Applied Biosystems), electrophoresed on
an ABI3100 Genetic Analyzer (Applied Biosystems), and
analyzed with Seqman software (Lasergene 8.0; DNASTAR,
Madison, WI). Any variant detected was initially confirmed
by bidirectional sequencing and then evaluated in 192 control
chromosomes of 96 normal individuals. Mutation description
followed  the  recommendation  of  the  Human  Genomic
Variation Society (HGVS).
RESULTS
Fourteen individuals in the family participated in this study
(Figure 1). The disease in the family had been passed in three
generations. Eight individuals in the family were considered
to be affected with adCOD based on clinical information
(Table 1; Figure 2, and Figure 3).
Two young affected girls (III:1 and III:2) in the family,
aged at two and a half years and nine months, respectively,
had no visual symptom at the time of examination (Figure 1
and Table 1). However, fundus observation revealed carpet-
like changes with multiple fine yellowish-white spots in the
macular region, as well as pallor in the temporal optic discs
of  these  two  girls  (Figure  2).  Electroretinography  (ERG)
recordings  demonstrated  reduced  cone  responses  that
confirmed the clinical findings (Figure 3).
For the other six adult patients, all had photophobia and
blurred  vision  noticed  at  about  6  to  8  years  old,  with
progressively decreased visual acuity thereafter. Night vision
in these patients was well preserved. Examination of Ishihara
color  plates  on  5  patients  suggested  color  vision  defects.
Macular atrophy and temporal pallor of the optic disc were
present in all six adult patients (Figure 2). Cone responses
were  significantly  reduced  in  three  adult  patients  who
received ERG examination (Figure 3). Rod responses were
normal in all five patients (three adults and two young girls),
as measured by ERG recordings (Figure 3).
Figure 3. Electroretinography of five patients and a normal control. Reduced photopic responses, abnormal 30 Hz ERG, and normal scotopic
Electroretinography (ERG) were shown in all five patients with ERG recordings (II:2, II:4, II:7, III:1, and III:2). Ctr: A normal control.
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3275The genome-wide linkage scan excluded linkage to other
regions and mapped the adCOD to 17p13.1 between D17S831
and D17S799, with a maximum lod score of 2.71 at theta=0
(Figure  1,  Table  2).  One  gene  known  to  cause  CORD,
GUCY2D, was present in the linkage interval. Subsequently,
sequencing  analysis  of  GUCY2D  detected  a  recurrent
heterozygous  mutation,  c.2513G>A  (p.Arg838His).  This
mutation  cosegregated  with  adCOD  in  the  family  with  a
maximum  lod  score  of  2.71,  but  was  not  present  in  six
unaffected family members or in 192 control chromosomes.
DISCUSSION
We identified a Chinese family with eight patients showing
signs of adCOD that was transmitted as autosomal dominant
trait in the family. A genome-wide linkage analysis mapped
the  disease  to  17p13.1  between  D17S831  and  D17S799.
Subsequent mutational screening of a candidate gene in the
linkage  interval  identified  a  recurrent  heterozygous  c.
2513G>A  (p.Arg838His)  mutation  in  GUCY2D.  This
mutation was present in all eight patients in the family, but
was  absent  in  unaffected  family  members  and  normal
controls. All of these lines of evidence support the view that
a mutation in GUCY2D is responsible for the adCOD in the
family.
To date, at least 125 mutations in GUCY2D have been
identified to be responsible for retinal degeneration, including
Leber  congenital  amaurosis,  CORD,  COD,  and  retinitis
pigmentosa, based on HGMD® Professional 2011 accessed
as of June 24, 2011. A review of the original reports revealed
that 10 of the 125 mutations were associated with COD or
CORD in 33 families (Table 3). For the 10 mutations in the
33 families, codon 838 accounted for six mutations (66.7%)
in 29 families (90.6%). Up to the present, all patients with
GUCY2D mutations at codon 838 exhibited COD or CORD
except for one patient, who had c.2513G>C (p.Arg838Pro)
and Leber congenital amaurosis, but no clinical details were
present [15]. It is unclear if there is any functional difference
among these different mutations involving codon 838.
Of  the  33  families  with  GUCY2D  mutations,  22  had
adCORD, 1 had arCORD, and 10 had adCOD. For the 10
adCOD  families,  5  had  the  c.2512C>T  (p.Arg838Cys)
mutation [9], 4 had the c.2513G>A (p.Arg838His) mutation
[9,16], and 1 had p.P575L mutation [17]. The phenotypes of
the patients were essentially similar but the ages at onset
varied significantly. In the Chinese family, photophobia and
TABLE 2. TWO-POINT LOD SCORES OF FAMILY FOR MARKERS AROUND GUCY2D.
  Position Lod score at theta=
Markers cM* Mb# 0 0.01 0.05 0.1 0.2 0.3 0.4
D17S849 0.6 0.43 -inf −3.61 −1.61 −0.82 −0.17 0.07 0.11
D17S831 6.6 1.91 -inf −1.33 −0.07 0.35 0.56 0.50 0.30
D17S938 14.8 6.25 2.71 2.67 2.49 2.25 1.74 1.16 0.53
GUCY2D   7.91 2.71 2.67 2.49 2.25 1.74 1.16 0.53
D17S1852 23.2 10.52 2.71 2.67 2.49 2.25 1.74 1.16 0.53
D17S799 32.8 13.17 -inf −1.33 −0.07 0.34 0.54 0.44 0.22
D17S921 37.3 14.26 -inf −1.62 −0.35 0.09 0.33 0.29 0.14
Genethon, # Homo genome (Build 37.2) Chr1 Primary_Assembly
TABLE 3. REPORTED GUCY2D MUTATIONS ASSOCIATED WITH CONE OR CONE-ROD DYSTROPHY.
No. Nucleotide change Residue change Families Phenotypes References
1 Unclear P575L 1 adCOD* [17]
2 2511_2512delGCinsCA [Glu837Asp,Arg838Ser] 1 adCORD [10,21]
3 2511_2516delGCGCACinsCTGCAT [Glu837Asp,Arg838Cys,Thr839Met] 1 adCORD [22]
4 2512C>T Arg838Cys 16 11/adCORD [9,10,18,21,23–25]
        5/adCOD [9]
5 2512C>G Arg838Gly 1 adCORD [9]
6 2513G>A Arg838His 9 5/adCORD [21,24–27]
        4/adCOD [9,16]
7 2513G>C Arg838Pro 1 1/adCORD [27]
8 2846T>C Ile949Thr 1 arCORD [28]
9 2540_2542delAGAinsTCC [Gln847Leu,Lys848Gln] 1 adCORD [29]
10 2744_2749delTCATTGinsCCATTC [I915T,G917R] 1 adCORD [24]
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3276poor vision was the initial symptom presented at age around
6 to 8 years old, which appeared earlier than those patients
with  the  p.Arg838His  mutations  in  previously  reported
families. In addition, the visual acuity for the Chinese patients
was generally worse than that for patients in previous reports.
The rod function in the Chinese patients was well preserved.
Our study provided clinical phenotypes for the two youngest
patients at ages less than two and half years old, while previous
studies only provided phenotypes for patients over 10 years
old.
Except for the common signs and symptoms for COD or
CORD, myopia has been reported as a common sign in several
families, such as myopia greater than 5D in at least one eye in
18 of 29 patients (62%) in a family with the p.Arg838Cys
mutation [18], myopia greater than 6D in all 10 patients of two
families with the p.Arg838His or Arg838Cys mutation [19],
and  moderate  myopia  in  patients  of  a  family  with  the  p.
[Glu837Asp, Arg838Ser] mutation [20]. In this study, high
myopia was present in five of the eight patients.
In summary, adCOD was identified in a Chinese family
and was caused by a recurrent mutation in GUCY2D. This is
the first report of GUCY2D mutation–associated adCOD in
the Chinese population. Fundus and ERG changes in the two
patients less than three years old provide the earliest signs for
adCOD, which would be valuable in clinical diagnosis.
ACKNOWLEDGMENTS
The authors thank all patients and family members for their
participation.  This  study  was  supported  by  the  National
Natural Science Foundation of China (30800615 to X.X.), the
National  Science  Fund  for  Distinguished  Young  Scholars
(30725044 to Q.Z.), and the Fundamental Research Funds of
State Key Lab of Ophthalmology, Sun Yat-sen University.
REFERENCES
1. Traboulsi EI. Genetic diseases of the eye. New York, Oxford,
1998.
2. Hamel CP. Cone rod dystrophies. Orphanet J Rare Dis 2007;
2:7. [PMID: 17270046]
3. Payne AM, Downes SM, Bessant DA, Taylor R, Holder GE,
Warren  MJ,  Bird  AC,  Bhattacharya  SS.  A  mutation  in
guanylate cyclase activator 1A (GUCA1A) in an autosomal
dominant cone dystrophy pedigree mapping to a new locus
on  chromosome  6p21.1.  Hum  Mol  Genet  1998;  7:273-7.
[PMID: 9425234]
4. Thiadens  AA,  den  Hollander  AI,  Roosing  S,  Nabuurs  SB,
Zekveld-Vroon RC, Collin RW, De Baere E, Koenekoop RK,
van Schooneveld MJ, Strom TM, van Lith-Verhoeven JJ,
Lotery AJ, van Moll-Ramirez N, Leroy BP, van den Born LI,
Hoyng CB, Cremers FP, Klaver CC. Homozygosity mapping
reveals PDE6C mutations in patients with early-onset cone
photoreceptor disorders. Am J Hum Genet 2009; 85:240-7.
[PMID: 19615668]
5. Yang  Z,  Peachey  NS,  Moshfeghi  DM,  Thirumalaichary  S,
Chorich L, Shugart YY, Fan K, Zhang K. Mutations in the
RPGR gene cause X-linked cone dystrophy. Hum Mol Genet
2002; 11:605-11. [PMID: 11875055]
6. Demirci FY, Rigatti BW, Wen G, Radak AL, Mah TS, Baic CL,
Traboulsi EI, Alitalo T, Ramser J, Gorin MB. X-linked cone-
rod dystrophy (locus COD1): identification of mutations in
RPGR exon ORF15. Am J Hum Genet 2002; 70:1049-53.
[PMID: 11857109]
7. Bergen AA, Pinckers AJ. Localization of a novel X-linked
progressive  cone  dystrophy  gene  to  Xq27:  evidence  for
genetic heterogeneity. Am J Hum Genet 1997; 60:1468-73.
[PMID: 9199568]
8. Nathans  J,  Davenport  CM,  Maumenee  IH,  Lewis  RA,
Hejtmancik JF, Litt M, Lovrien E, Weleber R, Bachynski B,
Zwas F, Klingaman R, Fishman G. Molecular genetics of
human blue cone monochromacy. Science 1989; 245:831-8.
[PMID: 2788922]
9. Kitiratschky VB, Wilke R, Renner AB, Kellner U, Vadala M,
Birch DG, Wissinger B, Zrenner E, Kohl S. Mutation analysis
identifies  GUCY2D  as  the  major  gene  responsible  for
autosomal dominant progressive cone degeneration. Invest
Ophthalmol Vis Sci 2008; 49:5015-23. [PMID: 18487367]
10. Kelsell RE, Gregory-Evans K, Payne AM, Perrault I, Kaplan J,
Yang  RB,  Garbers  DL,  Bird  AC,  Moore  AT,  Hunt  DM.
Mutations in the retinal guanylate cyclase (RETGC-1) gene
in  dominant  cone-rod  dystrophy.  Hum  Mol  Genet  1998;
7:1179-84. [PMID: 9618177]
11. Zhang Q, Zulfiqar F, Xiao X, Amer Riazuddin S, Ayyagari R,
Sabar  F,  Caruso  R,  Sieving  PA,  Riazuddin  S,  Fielding
Hejtmancik  J.  Severe  autosomal  recessive  retinitis
pigmentosa  maps  to  chromosome  1p13.3-p21.2  between
D1S2896 and D1S457 but outside ABCA4. Hum Genet 2005;
118:356-65. [PMID: 16189710]
12. Lathrop GM, Lalouel JM. Easy calculations of lod scores and
genetic risks on small computers. Am J Hum Genet 1984;
36:460-5. [PMID: 6585139]
13. Schäffer  AA,  Gupta  SK,  Shriram  K,  Cottingham  RW  Jr.
Avoiding  recomputation  in  linkage  analysis.  Hum  Hered
1994; 44:225-37. [PMID: 8056435]
14. Li L, Xiao X, Li S, Jia X, Wang P, Guo X, Jiao X, Zhang Q,
Hejtmancik  JF.  Detection  of  variants  in  15  genes  in  87
unrelated Chinese patients with Leber congenital amaurosis.
PLoS ONE 2011; 6:e19458. [PMID: 21602930]
15. Auz-Alexandre  CL,  Vallespin  E,  Aguirre-Lamban  J,
Cantalapiedra D, Avila-Fernandez A, Villaverde-Montero C,
Ainse  E,  Trujillo-Tiebas  MJ,  Ayuso  C.  Novel  human
pathological mutations. Gene symbol: GUCY2D. Disease:
Leber  congenital  amaurosis.  Hum  Genet  2009;  125:349.
[PMID: 19320033]
16. Kim BJ, Ibrahim MA, Goldberg MF. Use of Spectral Domain
OCT to Visualize Photoreceptor Abnormalities in Cone/Rod
Dystrophy-6. Retin Cases Brief Rep 2011; 5:56-61. [PMID:
21218126]
17. Small KW, Silva-Garcia R, Udar N, Nguyen EV, Heckenlively
JR. New mutation, P575L, in the GUCY2D gene in a family
with  autosomal  dominant  progressive  cone  degeneration.
Arch Ophthalmol 2008; 126:397-403. [PMID: 18332321]
18. Smith M, Whittock N, Searle A, Croft M, Brewer C, Cole M.
Phenotype of autosomal dominant cone-rod dystrophy due to
the R838C mutation of the GUCY2D gene encoding retinal
guanylate cyclase-1. Eye (Lond) 2007; 21:1220-5. [PMID:
17041576]
Molecular Vision 2011; 17:3271-3278 <http://www.molvis.org/molvis/v17/a352> © 2011 Molecular Vision
327719. Ito S, Nakamura M, Ohnishi Y, Miyake Y. Autosomal dominant
cone-rod dystrophy with R838H and R838C mutations in the
GUCY2D gene in Japanese patients. Jpn J Ophthalmol 2004;
48:228-35. [PMID: 15175914]
20. Gregory-Evans K, Kelsell RE, Gregory-Evans CY, Downes
SM, Fitzke FW, Holder GE, Simunovic M, Mollon JD, Taylor
R, Hunt DM, Bird AC, Moore AT. Autosomal dominant cone-
rod retinal dystrophy (CORD6) from heterozygous mutation
of  GUCY2D,  which  encodes  retinal  guanylate  cyclase.
Ophthalmology 2000; 107:55-61. [PMID: 10647719]
21. Payne AM, Morris AG, Downes SM, Johnson S, Bird AC,
Moore  AT,  Bhattacharya  SS,  Hunt  DM.  Clustering  and
frequency  of  mutations  in  the  retinal  guanylate  cyclase
(GUCY2D)  gene  in  patients  with  dominant  cone-rod
dystrophies. J Med Genet 2001; 38:611-4. [PMID: 11565546]
22. Perrault I, Rozet JM, Gerber S, Kelsell RE, Souied E, Cabot A,
Hunt DM, Munnich A, Kaplan J. A retGC-1 mutation in
autosomal dominant cone-rod dystrophy. Am J Hum Genet
1998; 63:651-4. [PMID: 9683616]
23. Van  Ghelue  M,  Eriksen  HL,  Ponjavic  V,  Fagerheim  T,
Andreasson S, Forsman-Semb K, Sandgren O, Holmgren G,
Tranebjaerg L. Autosomal dominant cone-rod dystrophy due
to a missense mutation (R838C) in the guanylate cyclase 2D
gene (GUCY2D) with preserved rod function in one branch
of the family. Ophthalmic Genet 2000; 21:197-209. [PMID:
11135490]
24. Ito S, Nakamura M, Nuno Y, Ohnishi Y, Nishida T, Miyake Y.
Novel complex GUCY2D mutation in Japanese family with
cone-rod  dystrophy.  Invest  Ophthalmol  Vis  Sci  2004;
45:1480-5. [PMID: 15111605]
25. Udar N, Yelchits S, Chalukya M, Yellore V, Nusinowitz S,
Silva-Garcia R, Vrabec T, Hussles Maumenee I, Donoso L,
Small KW. Identification of GUCY2D gene mutations in
CORD5  families  and  evidence  of  incomplete  penetrance.
Hum Mutat 2003; 21:170-1. [PMID: 12552567]
26. Weigell-Weber M, Fokstuen S, Torok B, Niemeyer G, Schinzel
A,  Hergersberg  M.  Codons  837  and  838  in  the  retinal
guanylate cyclase gene on chromosome 17p: hot spots for
mutations in autosomal dominant cone-rod dystrophy? Arch
Ophthalmol 2000; 118:300. [PMID: 10676808]
27. Garcia-Hoyos  M,  Auz-Alexandre  CL,  Almoguera  B,
Cantalapiedra D, Riveiro-Alvarez R, Lopez-Martinez MA,
Gimenez A, Blanco-Kelly F, Avila-Fernandez A, Trujillo-
Tiebas MJ, Garcia-Sandoval B, Ramos C, Ayuso C. Mutation
analysis at codon 838 of the Guanylate Cyclase 2D gene in
Spanish families with autosomal dominant cone, cone-rod,
and macular dystrophies. Mol Vis 2011; 17:1103-9. [PMID:
21552474]
28. Ugur Iseri SA, Durlu YK, Tolun A. A novel recessive GUCY2D
mutation  causing  cone-rod  dystrophy  and  not  Leber's
congenital amaurosis. Eur J Hum Genet 2010; 18:1121-6.
[PMID: 20517349]
29. Yoshida S, Yamaji Y, Yoshida A, Kuwahara R, Yamamoto K,
Kubata T, Ishibashi T. Novel triple missense mutations of
GUCY2D gene in Japanese family with cone-rod dystrophy:
possible  use  of  genotyping  microarray.  Mol  Vis  2006;
12:1558-64. [PMID: 17200655]
Molecular Vision 2011; 17:3271-3278 <http://www.molvis.org/molvis/v17/a352> © 2011 Molecular Vision
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China.
The print version of this article was created on 13 December 2011. This reflects all typographical corrections and errata to the
article through that date. Details of any changes may be found in the online version of the article.
3278